Amassive suspensionculturesystemwithmetabolic purification for human pluripotent stem cell-derived cardiomyocytes

Natsuko Hemmi, Shugo Tohyama, Kazuaki Nakajima, Hideaki Kanazawa, Tomoyuki Suzuki, Fumiyuki Hattori, Tomohisa Seki, Yoshikazu Kishino, Akinori Hirano, Marina Okada, Ryota Tabei, Rei Ohno, Chihana Fujita, Tomoko Haruna, Shinsuke Yuasa, Motoaki Sano, Jun Fujita, Keiichi Fukuda

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Cardiac regenerative therapy with human pluripotent stem cells (hPSCs), such as human embryonic stem cells and induced pluripotent stem cells, has been hamperedbythe lackofefficient strategies for expanding functional cardiomyocytes (CMs) to clinically relevant numbers. The development of the massive suspension culture system (MSCS) has shed light on this critical issue, although it remains unclear how hPSCs could differentiate into functional CMs using a MSCS. The proliferative rate of differentiating hPSCs in the MSCS was equivalent to that in suspension cultures using nonadherent culture dishes, although the MSCS provided more homogeneous embryoid bodies (EBs), eventually reducing apoptosis. However, pluripotent markers such as Oct3/4 and Tra-1-60 were still expressed in EBs 2 weeks after differentiation, even in the MSCS. The remaining undifferentiated stem cells in such cultures could retain a strong potential for teratoma formation, which is the worst scenario for clinical applications of hPSC-derived CMs. The metabolic purification of CMs in glucose-depleted and lactate-enriched medium successfully eliminated the residual undifferentiated stem cells, resulting in a refined hPSC-derived CM population. In colony formation assays, no Tra-1-60-positive colonies appeared after purification. The nonpurified CMs in the MSCS produced teratomas at a rate of 60%. However,purified CMs never induced teratomas, and enriched CMs showed proper electrophysiological properties and calcium transients. Overall, the combination of a MSCS and metabolic selection is a highly effective and practical approach to purify and enrich massive numbers of functional CMs and provides an essential technique for cardiac regenerative therapy with hPSC-derived CMs.

Original languageEnglish
Pages (from-to)1473-1483
Number of pages11
JournalStem cells translational medicine
Volume3
Issue number12
DOIs
Publication statusPublished - 2014

Fingerprint

Pluripotent Stem Cells
Cardiac Myocytes
Suspensions
Teratoma
Embryoid Bodies
Stem Cells
Induced Pluripotent Stem Cells
Lactic Acid
Apoptosis
Calcium
Glucose

Keywords

  • Cardiac
  • Cell culture
  • Cellular therapy
  • Differentiation
  • Embryonic stem cells
  • Induced pluripotent stem cells
  • Stem cell transplantation

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology

Cite this

Amassive suspensionculturesystemwithmetabolic purification for human pluripotent stem cell-derived cardiomyocytes. / Hemmi, Natsuko; Tohyama, Shugo; Nakajima, Kazuaki; Kanazawa, Hideaki; Suzuki, Tomoyuki; Hattori, Fumiyuki; Seki, Tomohisa; Kishino, Yoshikazu; Hirano, Akinori; Okada, Marina; Tabei, Ryota; Ohno, Rei; Fujita, Chihana; Haruna, Tomoko; Yuasa, Shinsuke; Sano, Motoaki; Fujita, Jun; Fukuda, Keiichi.

In: Stem cells translational medicine, Vol. 3, No. 12, 2014, p. 1473-1483.

Research output: Contribution to journalArticle

Hemmi, N, Tohyama, S, Nakajima, K, Kanazawa, H, Suzuki, T, Hattori, F, Seki, T, Kishino, Y, Hirano, A, Okada, M, Tabei, R, Ohno, R, Fujita, C, Haruna, T, Yuasa, S, Sano, M, Fujita, J & Fukuda, K 2014, 'Amassive suspensionculturesystemwithmetabolic purification for human pluripotent stem cell-derived cardiomyocytes', Stem cells translational medicine, vol. 3, no. 12, pp. 1473-1483. https://doi.org/10.5966/sctm.2014-0072
Hemmi, Natsuko ; Tohyama, Shugo ; Nakajima, Kazuaki ; Kanazawa, Hideaki ; Suzuki, Tomoyuki ; Hattori, Fumiyuki ; Seki, Tomohisa ; Kishino, Yoshikazu ; Hirano, Akinori ; Okada, Marina ; Tabei, Ryota ; Ohno, Rei ; Fujita, Chihana ; Haruna, Tomoko ; Yuasa, Shinsuke ; Sano, Motoaki ; Fujita, Jun ; Fukuda, Keiichi. / Amassive suspensionculturesystemwithmetabolic purification for human pluripotent stem cell-derived cardiomyocytes. In: Stem cells translational medicine. 2014 ; Vol. 3, No. 12. pp. 1473-1483.
@article{4944f5d0da914adbae1ec5a198e98e50,
title = "Amassive suspensionculturesystemwithmetabolic purification for human pluripotent stem cell-derived cardiomyocytes",
abstract = "Cardiac regenerative therapy with human pluripotent stem cells (hPSCs), such as human embryonic stem cells and induced pluripotent stem cells, has been hamperedbythe lackofefficient strategies for expanding functional cardiomyocytes (CMs) to clinically relevant numbers. The development of the massive suspension culture system (MSCS) has shed light on this critical issue, although it remains unclear how hPSCs could differentiate into functional CMs using a MSCS. The proliferative rate of differentiating hPSCs in the MSCS was equivalent to that in suspension cultures using nonadherent culture dishes, although the MSCS provided more homogeneous embryoid bodies (EBs), eventually reducing apoptosis. However, pluripotent markers such as Oct3/4 and Tra-1-60 were still expressed in EBs 2 weeks after differentiation, even in the MSCS. The remaining undifferentiated stem cells in such cultures could retain a strong potential for teratoma formation, which is the worst scenario for clinical applications of hPSC-derived CMs. The metabolic purification of CMs in glucose-depleted and lactate-enriched medium successfully eliminated the residual undifferentiated stem cells, resulting in a refined hPSC-derived CM population. In colony formation assays, no Tra-1-60-positive colonies appeared after purification. The nonpurified CMs in the MSCS produced teratomas at a rate of 60{\%}. However,purified CMs never induced teratomas, and enriched CMs showed proper electrophysiological properties and calcium transients. Overall, the combination of a MSCS and metabolic selection is a highly effective and practical approach to purify and enrich massive numbers of functional CMs and provides an essential technique for cardiac regenerative therapy with hPSC-derived CMs.",
keywords = "Cardiac, Cell culture, Cellular therapy, Differentiation, Embryonic stem cells, Induced pluripotent stem cells, Stem cell transplantation",
author = "Natsuko Hemmi and Shugo Tohyama and Kazuaki Nakajima and Hideaki Kanazawa and Tomoyuki Suzuki and Fumiyuki Hattori and Tomohisa Seki and Yoshikazu Kishino and Akinori Hirano and Marina Okada and Ryota Tabei and Rei Ohno and Chihana Fujita and Tomoko Haruna and Shinsuke Yuasa and Motoaki Sano and Jun Fujita and Keiichi Fukuda",
year = "2014",
doi = "10.5966/sctm.2014-0072",
language = "English",
volume = "3",
pages = "1473--1483",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "12",

}

TY - JOUR

T1 - Amassive suspensionculturesystemwithmetabolic purification for human pluripotent stem cell-derived cardiomyocytes

AU - Hemmi, Natsuko

AU - Tohyama, Shugo

AU - Nakajima, Kazuaki

AU - Kanazawa, Hideaki

AU - Suzuki, Tomoyuki

AU - Hattori, Fumiyuki

AU - Seki, Tomohisa

AU - Kishino, Yoshikazu

AU - Hirano, Akinori

AU - Okada, Marina

AU - Tabei, Ryota

AU - Ohno, Rei

AU - Fujita, Chihana

AU - Haruna, Tomoko

AU - Yuasa, Shinsuke

AU - Sano, Motoaki

AU - Fujita, Jun

AU - Fukuda, Keiichi

PY - 2014

Y1 - 2014

N2 - Cardiac regenerative therapy with human pluripotent stem cells (hPSCs), such as human embryonic stem cells and induced pluripotent stem cells, has been hamperedbythe lackofefficient strategies for expanding functional cardiomyocytes (CMs) to clinically relevant numbers. The development of the massive suspension culture system (MSCS) has shed light on this critical issue, although it remains unclear how hPSCs could differentiate into functional CMs using a MSCS. The proliferative rate of differentiating hPSCs in the MSCS was equivalent to that in suspension cultures using nonadherent culture dishes, although the MSCS provided more homogeneous embryoid bodies (EBs), eventually reducing apoptosis. However, pluripotent markers such as Oct3/4 and Tra-1-60 were still expressed in EBs 2 weeks after differentiation, even in the MSCS. The remaining undifferentiated stem cells in such cultures could retain a strong potential for teratoma formation, which is the worst scenario for clinical applications of hPSC-derived CMs. The metabolic purification of CMs in glucose-depleted and lactate-enriched medium successfully eliminated the residual undifferentiated stem cells, resulting in a refined hPSC-derived CM population. In colony formation assays, no Tra-1-60-positive colonies appeared after purification. The nonpurified CMs in the MSCS produced teratomas at a rate of 60%. However,purified CMs never induced teratomas, and enriched CMs showed proper electrophysiological properties and calcium transients. Overall, the combination of a MSCS and metabolic selection is a highly effective and practical approach to purify and enrich massive numbers of functional CMs and provides an essential technique for cardiac regenerative therapy with hPSC-derived CMs.

AB - Cardiac regenerative therapy with human pluripotent stem cells (hPSCs), such as human embryonic stem cells and induced pluripotent stem cells, has been hamperedbythe lackofefficient strategies for expanding functional cardiomyocytes (CMs) to clinically relevant numbers. The development of the massive suspension culture system (MSCS) has shed light on this critical issue, although it remains unclear how hPSCs could differentiate into functional CMs using a MSCS. The proliferative rate of differentiating hPSCs in the MSCS was equivalent to that in suspension cultures using nonadherent culture dishes, although the MSCS provided more homogeneous embryoid bodies (EBs), eventually reducing apoptosis. However, pluripotent markers such as Oct3/4 and Tra-1-60 were still expressed in EBs 2 weeks after differentiation, even in the MSCS. The remaining undifferentiated stem cells in such cultures could retain a strong potential for teratoma formation, which is the worst scenario for clinical applications of hPSC-derived CMs. The metabolic purification of CMs in glucose-depleted and lactate-enriched medium successfully eliminated the residual undifferentiated stem cells, resulting in a refined hPSC-derived CM population. In colony formation assays, no Tra-1-60-positive colonies appeared after purification. The nonpurified CMs in the MSCS produced teratomas at a rate of 60%. However,purified CMs never induced teratomas, and enriched CMs showed proper electrophysiological properties and calcium transients. Overall, the combination of a MSCS and metabolic selection is a highly effective and practical approach to purify and enrich massive numbers of functional CMs and provides an essential technique for cardiac regenerative therapy with hPSC-derived CMs.

KW - Cardiac

KW - Cell culture

KW - Cellular therapy

KW - Differentiation

KW - Embryonic stem cells

KW - Induced pluripotent stem cells

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=84913525381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913525381&partnerID=8YFLogxK

U2 - 10.5966/sctm.2014-0072

DO - 10.5966/sctm.2014-0072

M3 - Article

C2 - 25355733

AN - SCOPUS:84913525381

VL - 3

SP - 1473

EP - 1483

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 12

ER -